Back to calendar
CytomX Therapeutics, Inc. (CTMX) Earnings
CTMX reports earnings on Tuesday, November 10, 2026
earnings report
November 10, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.07
Actual EPS: $-0.09
EPS surprise: -16.76%
Company overview
Market Cap$732.1M
PriceUSD 3.36
EPS (TTM)-0.46
52-week high8.21
52-week low1.90
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees69